Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Neutralizing immunogen (NimIV) of rhinovirus and its uses for vaccine applications

Neutralizing immunogen (NimIV) of rhinovirus and its uses for vaccine applications

US Patent 9381237 · Granted Jul 5, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lipid nanoparticles for delivering mRNA vaccines2025
Antibodies against clostridium difficile toxins and methods of using the same2024
Lipid nanoparticles for delivering mRNA vaccines2023
Lipid nanoparticles for delivering mRNA vaccines2023
Methods of generating broadly protective vaccine compositions comprising hemaggl2023
Antibodies against Clostridium difficile toxins and methods of using the same2022
Synergistic co-administration of computationally optimized broadly reactive anti2021
Synergistic co-administration of computationally optimized broadly reactive anti2020
Synergistic co-administration of computationally optimized broadly reactive anti2019
Antibodies against Clostridium difficile toxins and methods of using the same2018
Recombinant bicistronic flavivirus vectors2016
Replication-defective flavivirus vaccines and vaccine vectors2015